Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

*see Various Departments* Alabama

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama 36420

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Anniston Alabama 36207-5710

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

View More ▼

Athens Alabama 35611

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham Alabama 35216

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham Alabama 35215

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham Alabama 35294

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham Alabama 35233

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Florence Alabama 35630

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Gulf Shores Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Jasper Alabama 35501

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Jasper Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Jasper Alabama

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Mobile Alabama 36608

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Montgomery Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Muscle Shoals Alabama 35662

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Sheffield Alabama 35660

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Arizona

Additional Locations Arizona

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Chandler Arizona 85284

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Flagstaff Arizona 86001

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Flagstaff Arizona 86001

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Glendale Arizona 85306

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

View More ▼

Glendale Arizona

A clinical trial seeking patients for a research study for the treatment of Lung Cancer or Non Small Cell Lung Cancer.

Peoria Arizona 85381

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Peoria Arizona 85381

Patients are needed to participate in a clinical research study of Lebrikizumab and Placebo to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Phoenix Arizona 85006

A clinical research study of Batefenterol + Fluticasone Furoate, Placebo and Albuterol for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Phoenix Arizona 85018

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix Arizona

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of Fluzone to evaluate Chronic Obstructive Pulmonary Disease

Redmond Arizona 97756

A clinical trial seeking patients for a research study for the treatment of Lung Cancer or Non Small Cell Lung Cancer.

Tempe Arizona 85283

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tucson Arizona 85723

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Tucson Arizona 85724-5023

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Tucson Arizona 85723

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tucson Arizona 85712

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tucson Arizona

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Arkansas

Fayetteville Arkansas 72703

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Fort Smith Arkansas 72901

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

California

Anaheim California 92801

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Arcadia California 91007

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Arcadia California

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Bakersfield California 93301

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Bakersfield California

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease